Search Results
10
Everything
Katapult Delivers Double-Digit Gross Originations Growth in the Fourth Quarter, Above Outlook
March 28, 2025 06:00 ET
|
Katapult Holdings, Inc.
Katapult reports strong Q4 and FY 2024 Results
Enlight Wins Israel’s First Ever Land Tender for an Integrated Data Center and Renewable Energy Facility in the Ashalim Region
March 28, 2025 06:00 ET
|
Enlight Renewable Energy Ltd.
TEL AVIV, Israel, March 28, 2025 (GLOBE NEWSWIRE) -- Enlight Renewable Energy (“Enlight”, "the Company”, NASDAQ: ENLT, TASE: ENLT.TA), a leading renewable energy platform, announced today that it...
Quantum Biopharma’s 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern
March 28, 2025 04:30 ET
|
Quantum BioPharma
TORONTO, March 28, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), has reported its financial and operational results...
Pharming Group to participate in April investor conferences
March 28, 2025 03:00 ET
|
Pharming Group N.V.
Leiden, the Netherlands, March 28, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor...
Dupixent® (dupilumab) Approved as the First-ever Biologic Medicine in Japan for Patients with Chronic Obstructive Pulmonary Disease (COPD)
March 28, 2025 02:00 ET
|
Regeneron Pharmaceuticals, Inc.
Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils Approval marks the first new treatment approach for...
Intchains Group Limited Announces Closing of Registered Direct Offering of its ADSs and Warrants
March 27, 2025 23:30 ET
|
Intchains Group Limited
SINGAPORE, March 27, 2025 (GLOBE NEWSWIRE) -- Intchains Group Limited (Nasdaq: ICG) (“we,” “us” or the “Company”), a company that engages in the provision of altcoin mining products, the strategic...
DBV Technologies Annonce un Financement pouvant atteindre 306,9 millions de dollars (284,5 millions d’euros) permettant d’avancer le programme Viaskin® Peanut jusqu’au dépôt d'une Demande de Licence Biologique (BLA) et d’assurer la...
March 27, 2025 22:30 ET
|
DBV Technologies S.A.
Châtillon, France, le 28 mars (3h30 CET) 2025 DBV Technologies Annonce un Financement pouvant atteindre 306,9 millions de dollars (284,5 millions d’euros) permettant d’avancer le programme Viaskin®...
DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved
March 27, 2025 22:30 ET
|
DBV Technologies S.A.
Châtillon, France, March 27, 2025 DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and...
Lantronix lanza nuevo Sistema en Módulo Open-Q 8550CS diseñado para satisfacer las necesidades de Edge AI Computing
March 27, 2025 20:43 ET
|
Lantronix, Inc.
IRVINE, California, March 27, 2025 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), un líder global de computación y conectividad para soluciones de IoT habilitando Edge AI Intelligence, anunció...
Lantronix bringt neues Open-Q 8550CS System-On-Module auf den Markt, das die Anforderungen von Edge-KI-Computing optimal erfüllt
March 27, 2025 20:43 ET
|
Lantronix, Inc.
IRVINE, Kalifornien, March 28, 2025 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), ein weltweit führender Anbieter von Rechen- und Konnektivitätslösungen für das Internet der Dinge (IoT), der...